{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:10:11Z","timestamp":1776820211582,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000961","name":"State Health Research Advisory Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000961","id-type":"DOI","asserted-by":"publisher"}]},{"name":"John Hunter Charitable Trust Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Delirium is defined as acute organic brain dysfunction characterised by inattention and disturbance of cognition. It is common in the intensive care unit and is associated with poorer outcomes. Good quality sleep is important in the prevention and management of delirium. Melatonin is a natural hormone secreted by the pineal gland which helps in the regulation of the sleep-wake cycle. It is possible that melatonin supplementation in intensive care improves sleep and prevents delirium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and design<\/jats:title>\n                <jats:p>The \u2018Prophylactic Melatonin for Delirium in Intensive Care\u2019 study is a multi-centre, randomised, double-blinded, placebo-controlled trial. The primary objective of this study is to determine whether melatonin given prophylactically decreases delirium in critically ill patients. A total of 850 ICU patients have been randomised (1:1) to receive either melatonin or a placebo. Participants were monitored twice daily for symptoms of delirium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This paper and the attached additional files describe the statistical analysis plan (SAP) for the trial. The SAP has been developed and submitted for publication before the database has been locked and before the treatment allocation has been unblinded. The SAP contains details of analyses to be undertaken, which will be reported in the primary and secondary publications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The SAP details the analyses that will be done to avoid bias coming from knowledge of the results in advance. This trial will determine whether prophylactic melatonin administered to intensive care unit patients helps decrease the rate and the severity of delirium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian and New Zealand Clinical Trial Registry (ANZCTR) <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=369434&amp;isReview=true\">ACTRN1261600043647<\/jats:ext-link>, registration date:\u00a006 April 2016. WHO Trial Number \u2013 U1111-1175-1814<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-020-04981-0","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T12:04:16Z","timestamp":1609848256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Bradley","family":"Wibrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-6685","authenticated-orcid":false,"given":"F. Eduardo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Kelty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Litton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erina","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"4981_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"4981_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00134-006-0399-8","volume":"33","author":"S Ouimet","year":"2007","unstructured":"Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33:66\u201373.","journal-title":"Intensive Care Med"},{"key":"4981_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","volume":"38","author":"JW Devlin","year":"2010","unstructured":"Devlin JW, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study*. Crit Care Med. 2010;38:419\u201327.","journal-title":"Crit Care Med"},{"key":"4981_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/CCM.0b013e3181c58715","volume":"38","author":"TD Girard","year":"2010","unstructured":"Girard TD, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial*. Crit Care Med. 2010;38:428\u201337.","journal-title":"Crit Care Med"},{"key":"4981_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccc.2009.05.003","volume":"25","author":"Y Skrobik","year":"2009","unstructured":"Skrobik Y. Delirium prevention and treatment. Crit Care Clin. 2009;25:585\u201391.","journal-title":"Crit Care Clin"},{"key":"4981_CR6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1164\/rccm.200904-0537OC","volume":"180","author":"MA Pisani","year":"2009","unstructured":"Pisani MA, et al. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180:1092\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4981_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/01.CCM.0000119429.16055.92","volume":"32","author":"EB Milbrandt","year":"2004","unstructured":"Milbrandt EB, et al. Costs associated with delirium in mechanically ventilated patients*. Crit Care Med. 2004;32:955\u201362.","journal-title":"Crit Care Med."},{"key":"4981_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox J, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. Jama. 2010;304:443\u201351.","journal-title":"Jama"},{"key":"4981_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/CCM.0000000000000727","volume":"43","author":"S Mehta","year":"2015","unstructured":"Mehta S, et al. Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults*. Crit Care Med. 2015;43:557\u201366.","journal-title":"Crit Care Med."},{"key":"4981_CR10","doi-asserted-by":"crossref","unstructured":"Trogrli\u0107 Z, et al. A systematic review of implementation strategies for assessment, prevention, and management of ICU delirium and their effect on clinical outcomes. Crit Care. 2015;19.","DOI":"10.1186\/s13054-015-0886-9"},{"key":"4981_CR11","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/cc13929","volume":"18","author":"AE Wolters","year":"2014","unstructured":"Wolters AE, et al. Long-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study. Crit Care. 2014;18:R125.","journal-title":"Crit Care"},{"key":"4981_CR12","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/s00134-001-1132-2","volume":"27","author":"E Ely","year":"2001","unstructured":"Ely E, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27:1892\u2013900.","journal-title":"Intensive Care Med"},{"key":"4981_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jcrc.2012.11.004","volume":"28","author":"S Yoshitaka","year":"2013","unstructured":"Yoshitaka S, et al. Perioperative plasma melatonin concentration in postoperative critically ill patients: its association with delirium. J Crit Care. 2013;28:236\u201342.","journal-title":"J Crit Care"},{"key":"4981_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3109\/00207454.2014.882919","volume":"124","author":"Y Wu","year":"2014","unstructured":"Wu Y, Wang J, Wu A, Yue Y. Do fluctuations in endogenous melatonin levels predict the occurrence of postoperative cognitive dysfunction (POCD)? Int J Neurosci. 2014;124:787\u201391.","journal-title":"Int J Neurosci"},{"key":"4981_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jclinane.2019.06.027","volume":"59","author":"KT Ng","year":"2020","unstructured":"Ng KT, Teoh WY, Khor AJ. The effect of melatonin on delirium in hospitalised patients: a systematic review and meta-analyses with trial sequential analysis. J Clin Anesth. 2020;59:74\u201381.","journal-title":"J Clin Anesth"},{"key":"4981_CR16","first-page":"122","volume":"10","author":"M Dianatkhah","year":"2015","unstructured":"Dianatkhah M, et al. Evaluating the potential effect of melatonin on the post-cardiac surgery sleep disorder. J Tehran Univ Heart Cent. 2015;10:122\u20138.","journal-title":"J Tehran Univ Heart Cent"},{"key":"4981_CR17","doi-asserted-by":"crossref","unstructured":"Artemiou, P. et al. ANAESTHESIOLOGY AND INTENSIVE CARE Melatonin treatment in the prevention of postoperative delirium in cardiac surgery patients. Pol J Cardio Thorac Surg 2, 126\u2013133 (2015).","DOI":"10.5114\/kitp.2015.52853"},{"key":"4981_CR18","doi-asserted-by":"publisher","first-page":"E547","DOI":"10.1503\/cmaj.140495","volume":"186","author":"A de Jonghe","year":"2014","unstructured":"de Jonghe A, et al. Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial. Can Med Assoc J. 2014;186:E547\u201356.","journal-title":"Can Med Assoc J"},{"key":"4981_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1658-354X.71132","volume":"4","author":"SS Sultan","year":"2010","unstructured":"Sultan SS. Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth. 2010;4:169.","journal-title":"Saudi J Anaesth"},{"key":"4981_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapsychiatry.2013.3320","volume":"71","author":"K Hatta","year":"2014","unstructured":"Hatta K, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014;71:397.","journal-title":"JAMA Psychiatry"},{"key":"4981_CR21","unstructured":"Abbasi S, Farsaei S, Ghasemi D, Mansourian M. Potential role of exogenous melatonin supplement in delirium prevention in critically ill patients: a double-blind randomized pilot study. Iran J Phar Res. 2018;17(4):1571\u201380."},{"key":"4981_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.amjmed.2018.04.009","volume":"131","author":"SJ Jaiswal","year":"2018","unstructured":"Jaiswal SJ, et al. Melatonin and sleep in preventing hospitalized delirium: a randomized clinical trial. Am J Med. 2018;131:1110\u20131117.e4.","journal-title":"Am J Med"},{"key":"4981_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/CCM.0000000000003132","volume":"46","author":"M Nishikimi","year":"2018","unstructured":"Nishikimi M, et al. Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: a single-center randomized placebo-controlled trial*. Crit Care Med. 2018;46:1099\u2013105.","journal-title":"Crit Care Med"},{"key":"4981_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/gps.2582","volume":"26","author":"T Al-Aama","year":"2011","unstructured":"Al-Aama T, et al. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry. 2011;26:687\u201394.","journal-title":"Int J Geriatr Psychiatry"},{"key":"4981_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jcrc.2015.04.005","volume":"30","author":"RB Serafim","year":"2015","unstructured":"Serafim RB, et al. Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care. 2015;30:799\u2013807.","journal-title":"J Crit Care"},{"key":"4981_CR26","doi-asserted-by":"crossref","unstructured":"Siddiqi N, Holt R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews: Wiley; 2007.","DOI":"10.1002\/14651858.CD005563.pub2"},{"key":"4981_CR27","doi-asserted-by":"publisher","unstructured":"Wang H, Chow S-C. Sample size calculation for comparing proportions. In: Wiley Encyclopedia of Clinical Trials: American Cancer Society; 2007. https:\/\/doi.org\/10.1002\/9780471462422.eoct005.","DOI":"10.1002\/9780471462422.eoct005"},{"key":"4981_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.305.6847.235","volume":"305","author":"SJ Pocock","year":"1992","unstructured":"Pocock SJ. When to stop a clinical trial. BMJ. 1992;305:235\u201340.","journal-title":"BMJ"},{"key":"4981_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1891\/1061-3749.8.2.131","volume":"8","author":"KC Richards","year":"2000","unstructured":"Richards KC, O\u2019Sullivan PS, Phillips RL. Measurement of sleep in critically ill patients. J Nurs Meas. 2000;8:131\u201344.","journal-title":"J Nurs Meas"},{"key":"4981_CR30","first-page":"406","volume":"78","author":"A Little","year":"2012","unstructured":"Little A, et al. A patient survey of sleep quality in the intensive care unit. Minerva Anestesiol. 2012;78:406\u201314.","journal-title":"Minerva Anestesiol"},{"key":"4981_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work?: multiple imputation by chained equations. Int J Methods Psychiatr Res. 2011;20:40\u20139.","journal-title":"Int J Methods Psychiatr Res"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-04981-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T12:04:33Z","timestamp":1609848273000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04981-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4981"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04981-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) on 23 October 2012, the Research Ethics Committee (REC) on 23 November 2012, and the respective National Health Service Research and Development (R&D) department on 15 February 2013. Consent was obtained from all participants prior to enrolment into the trial. Ethics approval was obtained to allow full informed consent or verbal assent (using a Brief Information Sheet) followed by full written consent at a later date.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual\u2019s data in any form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}